Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF‐beta and AKT/mTOR signaling pathways
Open Access
- 20 June 2021
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (6) , e377
Abstract
Although the treatment of osteosarcoma has improved, the overall survival rate of this common type of osseous malignancies has not changed for four decades. Thus, new targets for better therapeutic regimens are urgently needed. In this study, we found that high expression of clathrin heavy chain (CLTC) was an independent prognostic factor for tumor‐free survival (HzR, 3.049; 95% CI, 1.476–6.301) and overall survival (HzR, 2.469; 95% CI, 1.005–6.067) of patients with osteosarcoma. Down‐regulation of CLTC resulted in tumor‐suppressive effects in vitro and in vivo. Moreover, we found that CLTC was transcriptionally regulated by a transcription factor—specificity protein 1 (SP1), which binds to the CLTC promoter at the −320 to −314‐nt and +167 to +173‐nt loci. Mechanistic investigations further revealed that CLTC elicited its pro‐tumor effects by directly binding to and stabilizing trafficking from the endoplasmic reticulum to the Golgi regulator (TFG). Importantly, overexpression of TFG rescued both the tumor‐suppressive effect and inhibition of the TGF‐β and AKT/mTOR pathways caused by CLTC down‐regulation, which indicated that the activity of CLTC was TFG‐dependent. Immunohistochemistry analysis confirmed that CLTC expression was positively correlated with TFG expression. These findings collectively highlight CLTC as a new prognostic biomarker for patients with osteosarcoma, and the interruption of the SP1/CLTC/TFG axis may serve as a novel therapeutic strategy for osteosarcoma.Keywords
This publication has 49 references indexed in Scilit:
- MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1Molecular Cancer, 2013
- Clathrin and phosphatidylinositol-4,5-bisphosphate regulate autophagic lysosome reformationNature Cell Biology, 2012
- Transforming ER exit: protein secretion meets oncogenesisNature Cell Biology, 2011
- ER Stress Inhibits mTORC2 and Akt Signaling Through GSK-3β–Mediated Phosphorylation of RictorScience Signaling, 2011
- Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expressionMolecular Cancer, 2010
- Selective export of human GPI-anchored proteins from the endoplasmic reticulumJournal of Cell Science, 2010
- A census of human transcription factors: function, expression and evolutionNature Reviews Genetics, 2009
- ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphomaBlood, 2003
- Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumorGenes, Chromosomes and Cancer, 2002
- Mammalian Homologues of Yeast Sec31pJournal of Biological Chemistry, 2000